Delayed hyperacute rejection in recipients of kidney transplants from HLA identical sibling donors. 1979

J Montoliu, and J S Cheigh, and J A Mouradian, and M Suthanthiran, and R R Riggio, and A L Rubin, and K H Stenzel

Delayed hyperacute rejection, with its characteristic clinical course and histopathologic findings, occurred within one month after transplantation in five recipients of kidney transplants from HLA-A, B and D identical sibling donors. In all cases, unidirectional mixed lymphocyte cultures and immunologic studies to detect cytotoxic antibodies in the recipients against their respective donors, before kidney transplantation and after transplant nephrectomy, were unresponsive or negative. Onset of delayed hyperacute rejection was preceded by bacteremia in two of these patients. Two of these received second kidney transplants, three to six months later, from HLA-A, B and D identical sibling donors again. Although both have had an episode of acute rejection in the early postoperative period, the grafts have maintained excellent function for 21 and 25 months, respectively. Irreversible forms of transplant rejection, such as delayed hyperacute rejection, do occur even in recipients of kidney transplants from HLA-A, B and D identical sibling pairs, indicating that genetic determinants other than HLA-A, B and D loci, and perhaps other nongenetic immune mechanisms, play an important role in the ultimate results of kidney transplantation.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic

Related Publications

J Montoliu, and J S Cheigh, and J A Mouradian, and M Suthanthiran, and R R Riggio, and A L Rubin, and K H Stenzel
June 2016, Jornal brasileiro de nefrologia,
J Montoliu, and J S Cheigh, and J A Mouradian, and M Suthanthiran, and R R Riggio, and A L Rubin, and K H Stenzel
October 1976, Tissue antigens,
J Montoliu, and J S Cheigh, and J A Mouradian, and M Suthanthiran, and R R Riggio, and A L Rubin, and K H Stenzel
January 2006, Clinical transplants,
J Montoliu, and J S Cheigh, and J A Mouradian, and M Suthanthiran, and R R Riggio, and A L Rubin, and K H Stenzel
December 1992, Transplantation proceedings,
J Montoliu, and J S Cheigh, and J A Mouradian, and M Suthanthiran, and R R Riggio, and A L Rubin, and K H Stenzel
January 2024, HLA,
J Montoliu, and J S Cheigh, and J A Mouradian, and M Suthanthiran, and R R Riggio, and A L Rubin, and K H Stenzel
January 1986, Transplantation,
J Montoliu, and J S Cheigh, and J A Mouradian, and M Suthanthiran, and R R Riggio, and A L Rubin, and K H Stenzel
February 1989, Transplantation proceedings,
J Montoliu, and J S Cheigh, and J A Mouradian, and M Suthanthiran, and R R Riggio, and A L Rubin, and K H Stenzel
September 1978, Kidney international,
J Montoliu, and J S Cheigh, and J A Mouradian, and M Suthanthiran, and R R Riggio, and A L Rubin, and K H Stenzel
April 1992, Bone marrow transplantation,
J Montoliu, and J S Cheigh, and J A Mouradian, and M Suthanthiran, and R R Riggio, and A L Rubin, and K H Stenzel
April 2000, Bone marrow transplantation,
Copied contents to your clipboard!